Caris & Co Initiates Coverage on Kimberly-Clark (KMB) with a Below Average
More News related to KMB
- Kimberly-Clark (KMB) Reports Q2 Earnings, Reaffirms Outlook
- Kimberly-Clark Announces Full Details of Second Quarter 2008 Results
- Trading Radar for 7/24: Ford (F), Dow (DOW), Bristol-Myers (BMY), Potash (POT), National City (NCC), Eli Lilly (LLY) Report; Initial Jobless Claims and Existing Home Sales Due
- Kimberly-Clark to Webcast 2nd Quarter 2008 Earnings Conference Call
- David Moenning's Daily State of the Markets:
More News related to New Coverage
- CL King Starts Powerwave (PWAV) at Accumulate
- BMO Starts MAG Silver (MVG) at Outperform
- Morgan Keegan Starts Hanesbrands (HBI) at Outperform
- Wachovia Initiates MDC Partners (MDCA) with an Outperform
- Piper Jaffray Initiates Boston Scientific (BSX) with a Buy
Caris & Co initiates coverage on Kimberly-Clark (NYSE: KMB) with a Below Average. Price target $58.
Kimberly-Clark Corporation is a global health and hygiene company.
Related Categories
New CoverageStocks Mentioned
+0.94Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
